PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

Similar documents
Perioperative Infarcts: Epidemiology, predictors and post-op monitoring

Acute Coronary Syndrome. Sonny Achtchi, DO

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Post Operative Troponin Leak: David Smyth Christchurch New Zealand

What do the guidelines say?

Non ST Elevation-ACS. Michael W. Cammarata, MD

Acute Coronary Syndromes

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital

SESSION 5 2:20 3:35 pm

An update on the management of UA / NSTEMI. Michael H. Crawford, MD

Patient referral for elective coronary angiography: challenging the current strategy

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Perioperative Myocardial Infarction

Coronary Artery Disease: Revascularization (Teacher s Guide)

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Emergency surgery in acute coronary syndrome

Belinda Green, Cardiologist, SDHB, 2016

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

STEMI AND MULTIVESSEL CORONARY DISEASE

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute

The Universal Definition of Myocardial Infarction 3 rd revision, 2012

Coding an Acute Myocardial Infarction: Unravelling the Mystery

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

ST SEGMENT THE UPS AND THE DOWNS

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Perioperative Management After Coronary Stenting: Risk Assessment Before Surgery. Christian Seiler No conflict of interest to declare.

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Post-Procedural Myocardial Injury or Infarction

NSTE ACS. Timing of intervention

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust

Peri-operative Troponin Measurements - Pathophysiology and Prognosis

Acute coronary syndromes

South Afr J Anaesth Analg RESEARCH

Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Acute Coronary Syndromes. January 9, 2013 Chris Chiles M.D. FACC

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Preoperative Cardiac Risk Assessment: Approach & Guidelines

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Timing of Surgery After Percutaneous Coronary Intervention

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Benefit of Performing PCI Based on FFR

How will new high sensitive troponins affect the criteria?

ST Elevation Myocardial Infarction

10/22/16. Lay of the land. Definition of ACS. Why do we worry about ST elevations?

PERIOPERATIVE CARDIAC RISK ASSESSMENT. Divya Gollapudi, MD

Cindy L. Grines MD FACC FSCAI

Quinn Capers, IV, MD

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

2010 ACLS Guidelines. Primary goals of therapy for patients

Approach to Multi Vessel disease with STEMI

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

Early cardiology assessment and intervention reduces mortality following myocardial injury after non-cardiac surgery (MINS)

New universal definition of myocardial infarction

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Acute Coronary Syndrome

Preoperative Evaluation Guidelines and Work up

ST Elevation Myocardial Infarction

Treatment Options for Angina

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

REVISED MI DEFINITIONS IMPLICATIONS FOR CLINICAL TRIALS. Maarten L Simoons Thoraxcenter - Erasmus MC Rotterdam - The Netherlands

Diagnostics consultation document

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy

GUIDELINE 14 ACUTE CORONARY SYNDROMES

UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Cardiogenic Shock. Carlos Cafri,, MD

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

2010, Metzler Helfried

Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1)

Clopidogrel and ASA after CABG for NSTEMI

Acute Coronary Syndrome. Emergency Department Updated Jan. 2017

Appendix: ACC/AHA and ESC practice guidelines

Clinical Controversies in Perioperative Medicine

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Myocardial injury, necrosis and infarction

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

PCI for Left Anterior Descending Artery Ostial Stenosis

PACT module High risk surgical patient. Intensive Care Training Program Radboud University Medical Centre Nijmegen

FastTest. You ve read the book now test yourself

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Diagnostics guidance Published: 1 October 2014 nice.org.uk/guidance/dg15

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

Cardiovascular emergencies. 05/March/2014 László Rudas Szeged

Cangrelor: Is it the new CHAMPION for PCI? Robert Barcelona, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Intensive Care Unit November 13, 2015

Transcription:

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015

Disclosure Research funding received Medical Research Council (MRC) South Africa University of Kwazulu-Natal South African Society of Anaesthesiologists VISION (Vascular Events In Noncardiac Surgery) Troponin kits- Roche Diagnostics Over 50 grants internationally No other conflicts of interest 18 June 2015

Take home message Complex pathophysiology Little evidence to inform clinical guidelines 18 June 2015

Take home message Preoperative Coronary angiography does not identify the individual at risk Perioperative MI Difficult to determine the type of MI Postoperative Optimize medical therapy Stratify risk to determine appropriate coronary angiography 18 June 2015

Definition of Perioperative MI (PMI) Cardiac biomarker > 99th percentile upper ref limit and at least one of the following: Symptoms of ischaemia New ST T changes or LBBB Pathological Q waves New loss of viable myocardium Intracoronary thrombus 18 June 2015 Thygesen et al. J Am Coll Cardiol 2012;60(16):1581-98.

Peri-operative myocardial infarction (PMI) Type 2: Supply-demand Type 1: Plaque rupture Probability Coronary stenosis 50% 70% 100% 18 June 2015 Landesberg et al. J Cardiothorac Vasc Anesth 2003;17(1):90-100

Prevalence of coronary lesions in at risk surgical patients Author Type of study LMS >50% Surgically correctable >70% Hertzer, 1984 Vascular 4% 25% CARP, 2005 CTA VISION, 2015 Vascular considered at risk At risk of cardiovascular disease 4.7% 43.9% 1.3% 40.3% 18 June 2015

Coronary revascularisation Long-term MACE MACE major adverse cardiac events 18 June 2015 Biccard BM, Rodseth RN. Anaesthesia 2009;64(10):1105-13.

Problem no 1. Pre-noncardiac surgery MACE NNH 20 MACE major adverse cardiac events 18 June 2015 Biccard BM, Rodseth RN. Anaesthesia 2009;64(10):1105-13.

Problem no 2. Site of PMI Inducible myocardial ischaemia 56% evidence of infarction in other areas 18 June 2015 Poldermans et al. Am J Cardiol 2001;88(12):1413-4, A6.

Prediction of MACE from pre-op coronary lesions PPV NPV Coronary stenosis > 70% 12% 94% Coronary stenosis > 50% 10% 95% 18 June 2015 Sheth et al. BMJ 2015;350:h1907.

Coronary lesions to distinguish bet types of PMI Type 1 Rupture Type 2 Supply-demand LMS >50% 18% 19% 3 vessels >50% 47% 56% 2 vessels >50% 24% 22% 1 vessels >50% 18% 11% 0 vessels >50% 0% 6% 18 June 2015 Duvall et al. Catheter Cardiovasc Interv 2012;80(5):768-76.

18 June 2015 Garcia et al. Am J Cardiol 2008;102(7):809-13. Possible indications: 1. Left main stem stenosis

Possible indications: 2. Mod-sev inducible ischaemia 18 June 2015 Landesberg et al. Eur Heart J 2007;28(5):533-9.

Coronary lesions in PMI Type 2: Supply-demand Type 1: Plaque rupture Probability Coronary stenosis 50% 70% 100% 18 June 2015 Landesberg et al. J Cardiothorac Vasc Anesth 2003;17(1):90-100

PATHOPHYSIOLOGY OF PERIOPERATIVE MI 18 June 2015

Clinical presentation PMI Presents predominantly as a non-occlusive lesion Type of myocardial ischaemia ST depression 40x> ST elevation Postoperative troponin release Postoperative ischaemia > 10min 18 June 2015 Landesberg G et al. J Am Coll Cardiol 2004;44(3):569-75.

Clinical presentation PMI Inflammation Coagulation Stress state Hypoxia Thrombosis Myocardial ischaemia Peri-operative myocardial injury 18 June 2015 Devereaux et al. CMAJ 2005; 173: 627-34

Clinical presentation PMI 18 June 2015 Beattie WS, et al. Anesth Analg 2008; 106: 1039-48

Clinical presentation PMI 18 June 2015 Devereaux et al. Ann Intern Med 2011;154(8):523-28

Intracoronary thrombus formation Flow separation 18 June 2015 Biccard and Rodseth. Anaes 2010; 65: 733-41

Intracoronary thrombus formation Thrombus Recirculation and stasis zone 18 June 2015 Biccard and Rodseth. Anaes 2010; 65: 733-41

Predictors of PMI 18 June 2015 Devereaux et al. N Engl J Med 2014;370(16):1504-13.

Time of presentation Type 1 Rupture Type 2 Supply-demand 7.4+4.4 4.4+4.8 Later, spontaneous presentation Earlier presentation 18 June 2015 Biccard and Rodseth. Anaes 2010; 65: 733-41

Troponin release Type 1 and 2 PMI Type 2 PMI 18 June 2015 Le Manach et al. Anesthesiology 2005; 102: 885-91

Summary of PMI Characteristic Type 1 Rupture Coronary stenoses >50% >95% of all PMI Type 2 Supply-demand Incidence 44-55% 45-56% Multivessel coronary stenoses 92% 86% Presence intraluminal thrombus 52-66% 0-7% Postoperative day of presentation 7.4+4.4 4.4+4.8 Pathophysiology Complex perioperative physiology 18 June 2015 Biccard BM, Rodseth RN. Anaesthesia 2010;65(7):733-41.

Summary of PMI Coronary stenoses are common High likelihood of intraluminal thrombus without total occlusion Majority can t distinguish on clinical presentation 18 June 2015 Biccard and Rodseth. Anaes 2010; 65: 733-41

MANAGEMENT OF PERIOPERATIVE MYOCARDIAL INFARCTION 18 June 2015

Possible management following PMI Oxygen, Optimize haemoglobin Aspirin +/- clopidogrel Statin, ACE-inhibitor Anticoagulation +/- morphine, +/- nitroglycerine Haemodynamically stable Haemodynamically unstable Beta-blockade Manage hypotension and dysrhythmias Add beta-blocker when stable Consider coronary angiogram if; 1. ST elevation 2. ST depression with recurrent symptoms and no contra-indication to heparin 18 June 2015 Biccard. Curr Opin Anaesthesiol 2014;27(3):336-43.

Possible management following PMI Drug therapy intensification No PMI No drug therapy intensification 18 June 2015 Fourcier et al. Anesth Analg 2014;119(5):1053-63.

POST PMI CORONARY ANATOMY 18 June 2015

Indications for coronary angiography Indication Appropriate Potential perioperative Use equivalent Suspected CAD: No prior imaging Symptomatic with a Score (1 9) A (7) PMI following high pretest probability vascular surgery (>90% CAD) CTA VISION pretest probability for CAD following PMI is 92% 18 June 2015 Patel MR et al. J Am Coll Cardiol 2012;59: 1995-2027

Prevalence of surgically correctable coronary disease Lesion Procedure Class of evidence Preoperative Post PMI Unprotected LMS CABG/ PCI I/ IIa 4% (Hertzer) 15% (Duvall) 3 vessel CABG I 11% (Hertzer) 2 vessel with proximal LAD CABG I 9.4% (CTA VISION) 27% (CTA VISION) 18 June 2015 Jneid et al. Circulation 2012;126(7):875-910.

Early Delayed Contra-indicated TIMING OF CORONARY CATHETERIZATION 18 June 2015

Indications for immediate/ early coronary angiography STEMI Cardiogenic shock due to suspected ACS 18 June 2015 Patel et al. J Am Coll Cardiol 2012;59(22):1995-2027.

Evidence for early interventional strategy Presentation Medical therapy Invasive coronary intervention Haemodynamically stable 10 3 Haemodynamically unstable 15 47 P-value 0.0006 18 June 2015 Ryan et al. SAJAA 2012;18(2):86-93.

Mortality associated with early interventional strategy Mortality Medical therapy Invasive coronary intervention P-value Haemodynamically unstable 40% 29.8% 0.53 18 June 2015 Ryan et al. SAJAA 2012;18(2):86-93.

Early invasive strategy following NSTEMI Indication Class Refractory angina or haemodynamic or electrical instability I Stabilized, no serious comorbidities and risk of clinical events I Initially stabilized high-risk patients IIa 18 June 2015 Jneid et al. Circulation 2012;126(7):875-910.

Predictors of 30 day mortality following MINS Risk factor Adjusted OR (95% CI) Age 75 years old (1 point) 2.06 (1.33-3.37) ST elevation or new LBBB (2 points) 3.96 (1.54-9.14) Anterior ischaemic ECG findings (1 point) 2.33 (1.42-3.70) 18 June 2015 Botto et al. Anesthesiology 2014;120(3):564-78.

30-day mortality, % Predictors of 30 day mortality following MINS 70 60 50 40 30 20 10 0 9.8% 0 1 2 3 4 Total points Model Observed 18 June 2015 Botto et al. Anesthesiology 2014;120(3):564-78.

Early invasive strategy following NSTEMI: No benefit Indication Class Extensive comorbidities e.g. liver, pulmonary failure, cancer III With a low likelihood of ACS III 18 June 2015 Jneid et al. Circulation 2012;126(7):875-910.

Balance of risks and benefits Revascularization Medical therapy 18 June 2015

Risk: Bleeding 18 June 2015 Devereaux et al. N Engl J Med 2014;370(16):1494-503.

Conservative management following NSTEMI Class I recommendation if an initial conservative strategy is selected and no subsequent features appear that would necessitate diagnostic angiography then a stress test should be performed 18 June 2015 Jneid et al. Circulation 2012;126(7):875-910.

Conclusions Preoperative Coronary angiography does not identify the individual at risk Perioperative MI Difficult to determine the type of MI Postoperative Optimize medical therapy Stratify risk to determine appropriate coronary angiography 18 June 2015